The Trump Administration will explore new payment models for prescription drugs at the Center for Medicare and Medicaid Innovation (CMMI) as part of a plan to redirect the focus of the reimbursement laboratory.
The Centers for Medicare and Medicaid Services released a "request for information" Sept. 20 seeking public comments on...